Hjem › Migræne › North Carolina
Migræne kliniske forsøg i North Carolina
12 studier for Migræne søger deltagere på steder i North Carolina.
Byer i North Carolina
Officiel studietekst (engelsk)
Study of EVO756 in Adults With Migraine
- Asheville Neurology Specialists, Pa, Asheville
- Eximia Research NC, Raleigh
RekruttererFase 2
Alder 18 til 64 · Alle køn · Opdateret 2. okt. 2026 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Accellacare - Piedmont, Statesville
- Accellacare of Piedmont HealthCare, Statesville
- Accellacare US Inc., Winston-Salem
RekruttererFase 1
Alder 6 til 11 · Alle køn · Opdateret 28. sep. 2026 · NCT06995729Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- OnSite Clinical Solutions, LLC, Charlotte
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- OnSite Clinical Solutions, LLC, Charlotte
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT04649242Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Onsite Clinical Solutions Park Cedar Dr., Charlotte
- Onsite Clinical Solutions Mecklenburg, Charlotte
- Onsite Clinical Solutions Ballantyne, Charlotte
- og 2 flere
RekruttererFase 4
Alder 18 til 70 · Alle køn · Opdateret 16. sep. 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Onsite Clinical Solutions - Don Lochman Lane - Charlotte /ID# 282834, Charlotte
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 14. sep. 2026 · NCT05125302A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
- Queen City Clinical Research, PLLC, Charlotte
Rekrutterer
Alder 22 til 84 · Alle køn · Opdateret 28. aug. 2026 · NCT07719608A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- OnSite Clinical Solutions, Charlotte
- Guildford Neurologic Research Partners, LLC, Greensboro
- Headache Wellness Center, Greensboro
- og 2 flere
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 20. aug. 2026 · NCT07645924BE WELL With Migraine: Brain Education and WELLness With Migraine
- Wake Forest University Health Sciences, Winston-Salem
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 12. jun. 2026 · NCT05987592Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- Evidera, a PPD business unit, Wilmington
RekruttererObservationsstudie
Alder 0 og opefter · Kvinder · Opdateret 5. maj 2026 · NCT05046613Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
- Iqvia /Id# 266904, Durham
RekruttererObservationsstudie
Alder 18 og opefter · Kvinder · Opdateret 15. dec. 2025 · NCT05158894Aimovig Pregnancy Exposure Registry
- IQVIA Virtual Site, Durham
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 99 · Kvinder · Opdateret 4. nov. 2025 · NCT06150781Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.